Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BI 44370 TA in Healthy Males
NCT02215018Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2007
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of BI 44370 in migraine (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of patients with adverse events, Number of patients with clinically significant findings in vital signs and 3 more. Started Apr 2007; status: completed.
02
Drugs
BI 44370
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02215018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215018.